Indication: Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogs.

Composition: Each ml contains Dorzolamide hydrochloride 2% (20 mg/ml) and Timolol 0.5% (5 mg/ml), preserved with 0.075 mg Benzalkonium chloride.

Pack Size: 5ml

Form: Eye Drops

Manufacturer: Orchidia Pharmaceutical Industries

Manufacturing Country: Egypt

Registration Number: 90118/1